chr2-203867965-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_005214.5(CTLA4):c.23G>A(p.Arg8Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R8L) has been classified as Uncertain significance.
Frequency
Consequence
NM_005214.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CTLA4 | NM_005214.5 | c.23G>A | p.Arg8Gln | missense_variant | 1/4 | ENST00000648405.2 | |
CTLA4 | NM_001037631.3 | c.23G>A | p.Arg8Gln | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CTLA4 | ENST00000648405.2 | c.23G>A | p.Arg8Gln | missense_variant | 1/4 | NM_005214.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152116Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251380Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135858
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461776Hom.: 0 Cov.: 29 AF XY: 0.0000289 AC XY: 21AN XY: 727198
GnomAD4 genome AF: 0.000190 AC: 29AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74432
ClinVar
Submissions by phenotype
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Oct 11, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 28, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 475275). This variant has not been reported in the literature in individuals affected with CTLA4-related conditions. This variant is present in population databases (rs138279736, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 8 of the CTLA4 protein (p.Arg8Gln). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at